RIV Capital Inc. (C:RIV)
Business Focus: Alternative Medicine
| Sector: Healthcare | Industry: Pharmaceuticals |
| Company Contact | |
| Address: | 40 King Street West, Suite 2504 TORONTO ON M5H 3Y2 |
| Tel: | N/A |
| Website: | https://www.rivcapital.com |
| IR: | See website |
| Key People | ||
| Joseph Mimran Independent Chairman of the Board | Mike Totzke Interim Chief Executive Officer, Chief Operating Officer | Edward Lucarelli Chief Financial Officer |
| Amanda Rico Chief Human Resource Officer | Matthew Mundy General Counsel, Corporate Secretary, Chief Strategy Officer | |
| Business Overview |
| RIV Capital Inc. is a Canada-based acquisition and investment company. The Company is focused on the United States (U.S.) cannabis market by acquiring, investing in, and developing operators and brands to create a multistate platform. The Company is a direct parent company of RIV Capital US Corporation and RIV Capital Corporation and exercises financial control over Etain, LLC. Through its strategic relationship with The Hawthorne Collective, Inc. (The Hawthorne Collective), a subsidiary of The ScottsMiracle-Gro Company (ScottsMiracle-Gro), the Company is The Hawthorne Collective's preferred vehicle for cannabis-related investments not under the purview of other ScottsMiracle-Gro subsidiaries. The Company's subsidiaries include 2683922 Ontario Inc., RIV Capital US Corporation, RIV Capital US Holdings LLC, RIV Capital US Real Estate LLC and RIV Capital US Services LLC. |
| Financial Overview |
| For the six months ended 30 September 2023, RIV Capital Inc revenues increased 9% to $3.5M. Net loss decreased 89% to $16.5M. Revenues reflect Revenue increase of 9% to $3.7M. Lower net loss reflects Impairment of goodwill decrease from $138.9M (expense) to $0K, Other Expense (income), net increase from $71K to $902K (income), FV Adjustments on Biological Assets decrease from $100K (expense) to $411K (income). |
| Employees: | 23 as of Mar 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $32.10M as of Sep 30, 2023 |
| Annual revenue (TTM): | $9.77M as of Sep 30, 2023 |
| EBITDA (TTM): | -$23.65M as of Sep 30, 2023 |
| Net annual income (TTM): | -$68.81M as of Sep 30, 2023 |
| Free cash flow (TTM): | -$38.74M as of Sep 30, 2023 |
| Net Debt Last Fiscal Year: | $45.70M as of Sep 30, 2023 |
| Shares outstanding: | 135,680,154 as of Sep 30, 2023 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
